Control Bionics Ltd. announced the appointment of Jeremy Steele as Chief Executive Officer, effective from 19 January 2023. Mr. Steele brings over 25 years of global corporate experience across a wide range of industries including healthcare, software, financial services and retail in senior roles, including most recently as Executive Chairman and subsequently CEO of CardioScan. Mr. Steele will initially be based in his current location of Singapore, in the midst of key Australasian markets and may transition to the CBL office in Melbourne over time.

The Board also acknowledged founder and interim CEO, Peter Ford for his leadership of the company in the period up to the appointment of Mr. Steele.